Matthew is responsible for assisting in the development of economic models and budget impact models (BIMs), performing literature reviews and data extractions, and assisting with the writing of reports, manuscripts, and presentations. Prior to his current role, Matthew was employed for over a decade as a program evaluator at an established Canadian research firm, where he designed, implemented, and managed assessments of the value for money derived from activities, programs, and initiatives undertaken by public, private, and not-for-profit sector clients. Notable examples include a cost-effectiveness analysis of implementing evidence-informed primary care for patients with type 2 diabetes mellitus (T2DM) in the province of Manitoba; and, an economic evaluation of implementing medication reconciliation in Canadian acute care facilities to reduce the frequency of preventable adverse drug events. Before that, he served as an economist at Brogan Inc., where he participated in the development of BIMs for new pharmaceuticals and biologics seeking reimbursement in Canadian provinces and territories. In addition to budgetary impact modeling, Matthew is experienced with a range of standard modeling and simulation techniques (e.g., Markov cohort and individual simulation).
Matthew holds a Bachelor of Arts degree in economics from the University of Winnipeg, and a Master of Arts and PhD – both with a concentration in health economics—from McMaster University and the University of Manitoba, respectively. His doctoral research focuses on modeling optimal health-related, patient decision-making in the context of T2DM.